Human Lipoxygenase Pathway Gene Variation and Association with Markers of Subclinical Atherosclerosis in the Diabetes Heart Study

Table 1

Clinical and laboratory characteristics of Caucasian DHS participants.

	Diabetic patients ($n=828$)	Nondiabetic patients ($n=170$)
Age (years)	62.0 ± 9.3	59.5 ± 10.0
Female (%)	51.20%	61.80%
Diabetes duration (years)	10.4 ± 7.1
BMI (kg/m${}^2$)	32.4 ± 6.7	28.9 ± 5.2
Cholesterol (mmol/L )	4.8 ± 1.1	5.0 ± 0.9
HDL (mmol/L)	1.1 ± 0.3	1.2 ± 0.4
LDL (mmol/L)	2.7 ± 0.8	2.9 ± 0.8
CRP (mg/L)	5.1 ± 8.3	4.1 ± 6.5
Smoking (current/past) (%)	59.40%	57.40%
Lipid lowering (%)	45.40%	27.80%
Estrogen (%, in women)	26.60%	34.80%
Aspirin (%)	57.60%	53.30%
Hypertension (%)	79.40%	46.50%